Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 83.04M | 83.07M | 106.04M | 104.51M | 60.40M | 45.16M |
Gross Profit | 13.87M | 14.40M | 18.73M | 21.09M | 12.24M | 7.33M |
EBITDA | 923.42K | -323.37K | 6.58M | 8.27M | 3.93M | -1.89M |
Net Income | -2.11M | -3.85M | 909.41K | 8.64M | 1.32M | -5.15M |
Balance Sheet | ||||||
Total Assets | 53.40M | 58.17M | 68.37M | 78.50M | 43.80M | 26.29M |
Cash, Cash Equivalents and Short-Term Investments | 0.00 | 0.00 | 0.00 | -1.94M | -7.48M | -1.78M |
Total Debt | 19.46M | 17.70M | 31.00M | 39.59M | 23.89M | 12.63M |
Total Liabilities | 34.00M | 38.56M | 45.83M | 56.09M | 32.08M | 15.73M |
Stockholders Equity | 19.41M | 19.61M | 22.54M | 22.41M | 11.72M | 10.56M |
Cash Flow | ||||||
Free Cash Flow | 6.68M | 9.97M | 12.00M | -10.67M | -9.26M | 10.22M |
Operating Cash Flow | 6.96M | 10.39M | 12.69M | -8.57M | -9.22M | 10.22M |
Investing Cash Flow | -277.82K | -414.09K | -676.64K | -2.10M | 40.11K | 1.43K |
Financing Cash Flow | -6.68M | -9.97M | -12.01M | 10.67M | 9.18M | -10.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | 529.16M | 8.22 | 11.34% | 2.67% | 14.74% | 62.76% | |
74 Outperform | 187.10M | 4.75 | ― | ― | 18.15% | -75.41% | |
63 Neutral | 394.25M | -19.34 | -5.13% | ― | -6.25% | -129.86% | |
58 Neutral | 11.05M | 0.41 | 123.85% | ― | -82.87% | ― | |
56 Neutral | 299.75M | 30.40 | 1.50% | ― | -4.63% | -92.13% | |
46 Neutral | C$7.53M | ― | -10.30% | ― | -11.74% | -10.97% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |
Bri-Chem Corp. reported a significant decline in its financial performance for the fourth quarter of 2024, with consolidated sales dropping by 23% to $20.6 million due to decreased U.S. drilling activity. The company’s adjusted EBITDA and operating earnings also saw substantial decreases, alongside a notable reduction in working capital, which was impacted by a loan classification change. Despite these challenges, Bri-Chem received a waiver for a covenant breach from its lender, indicating ongoing financial adjustments and potential future stability.